Key result
Streptokinase resolves catheter-induced subclavian vein thrombosis in a patient unresponsive to heparin.
Why the study?
Does streptokinase therapy improve outcomes in a patient with catheter-induced subclavian vein thrombosis refractory to heparin?
Population
1 patient with symptomatic subclavian vein thrombosis receiving long-term parenteral nutrition
Comparison
Fibrinolytic therapy with streptokinase… vs Prior therapy with heparin
Design
Case_report
Authors
Loading...
Streptokinase may resolve heparin-refractory subclavian thrombosis; single case leaves open efficacy, safety, and need for trials.
Case Report (n=1)
Does streptokinase therapy improve outcomes in a patient with catheter-induced subclavian vein thrombosis refractory to heparin?
Streptokinase may be an effective treatment for catheter-induced subclavian vein thrombosis when heparin fails.
M. Rubenstein (1980) conducted a case report in Catheter-Induced Subclavian Vein Thrombosis (n=1). Streptokinase vs. Heparin was evaluated on Treatment success. Fibrinolytic therapy with streptokinase was strikingly successful in treating catheter-induced subclavian vein thrombosis in a patient unresponsive to heparin.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: